- Home
- EFR vs LRMR Comparison
EFR vs LRMR Comparison
Compare EFR & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- LRMR
- Stock Information
- Founded
- EFR 2003
- LRMR N/A
- Country
- EFR United States
- LRMR United States
- Employees
- EFR N/A
- LRMR N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- EFR Finance
- LRMR Health Care
- Exchange
- EFR Nasdaq
- LRMR Nasdaq
- Market Cap
- EFR 342.8M
- LRMR 309.8M
- IPO Year
- EFR N/A
- LRMR N/A
- Fundamental
- Price
- EFR $11.58
- LRMR $4.08
- Analyst Decision
- EFR
- LRMR Strong Buy
- Analyst Count
- EFR 0
- LRMR 7
- Target Price
- EFR N/A
- LRMR $18.43
- AVG Volume (30 Days)
- EFR 88.6K
- LRMR 1.3M
- Earning Date
- EFR 01-01-0001
- LRMR 10-29-2025
- Dividend Yield
- EFR 9.43%
- LRMR N/A
- EPS Growth
- EFR N/A
- LRMR N/A
- EPS
- EFR 1.69
- LRMR N/A
- Revenue
- EFR N/A
- LRMR N/A
- Revenue This Year
- EFR N/A
- LRMR N/A
- Revenue Next Year
- EFR N/A
- LRMR N/A
- P/E Ratio
- EFR $7.74
- LRMR N/A
- Revenue Growth
- EFR N/A
- LRMR N/A
- 52 Week Low
- EFR $10.95
- LRMR $1.61
- 52 Week High
- EFR $13.29
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- EFR 34.37
- LRMR 57.29
- Support Level
- EFR $11.10
- LRMR $3.84
- Resistance Level
- EFR $11.71
- LRMR $4.26
- Average True Range (ATR)
- EFR 0.11
- LRMR 0.28
- MACD
- EFR -0.00
- LRMR 0.00
- Stochastic Oscillator
- EFR 72.73
- LRMR 71.10
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.